BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32281437)

  • 1. Mycophenolate mofetil and lichen planopilaris: systematic review and meta-analysis.
    Mostafa N; Phan K; Smith S
    J Dermatolog Treat; 2022 Feb; 33(1):369-372. PubMed ID: 32281437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of lichen planopilaris with mycophenolate mofetil.
    Tursen U; Api H; Kaya T; Ikizoglu G
    Dermatol Online J; 2004 Jul; 10(1):24. PubMed ID: 15347506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of mycophenolate mofetil for lichen planopilaris.
    Cho BK; Sah D; Chwalek J; Roseborough I; Ochoa B; Chiang C; Price VH
    J Am Acad Dermatol; 2010 Mar; 62(3):393-7. PubMed ID: 20061053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of mychophenolate mofetil in treating lichen planopilaris.
    Azizpour A; Hatami P; Lajevardi V; Mohammadi M; Aryanian Z; Mohandesi NA
    Dermatol Ther; 2022 Aug; 35(8):e15625. PubMed ID: 35674693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review and Bayesian Network Meta-Analysis of Medical Therapies for Lichen Planopilaris.
    Husein-ElAhmed H; Husein-ElAhmed S
    Dermatology; 2024; 240(1):103-110. PubMed ID: 37852211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of systemic mycophenolate mofetil with topical clobetasol in lichen planopilaris: a parallel-group, assessor- and analyst-blinded, randomized controlled trial.
    Lajevardi V; Ghodsi SZ; Goodarzi A; Hejazi P; Azizpour A; Beygi S
    Am J Clin Dermatol; 2015 Aug; 16(4):303-311. PubMed ID: 25786714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Patterns for Hydroxychloroquine, Methotrexate, and Mycophenolate Mofetil in Lichen Planopilaris: A Retrospective Chart Review.
    Williams J; Lacy A; Ranpariya VK; Pichardo RO
    J Cutan Med Surg; 2023; 27(4):403-405. PubMed ID: 37559372
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: a meta-analysis of randomized controlled trials.
    Liu LL; Jiang Y; Wang LN; Yao L; Li ZL
    Drugs; 2012 Jul; 72(11):1521-33. PubMed ID: 22818016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of hydroxychloroquine in the treatment of lichen planopilaris: A retrospective case series and review.
    Nic Dhonncha E; Foley CC; Markham T
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28168851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lichen planopilaris: update on pathogenesis and treatment.
    Baibergenova A; Donovan J
    Skinmed; 2013; 11(3):161-5. PubMed ID: 23930355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolic acid in dermatology a century after its discovery.
    Strathie Page SJ; Tait CP
    Australas J Dermatol; 2015 Feb; 56(1):77-83. PubMed ID: 25557632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of effect of empirical attack-preventive immunotherapies in neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis.
    Ma J; Yu H; Wang H; Zhang X; Feng K
    J Neuroimmunol; 2022 Feb; 363():577790. PubMed ID: 34959021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil in erosive genital lichen planus: a case and review of the literature.
    Deen K; McMeniman E
    J Dermatol; 2015 Mar; 42(3):311-4. PubMed ID: 25583369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil and atopic dermatitis: systematic review and meta-analysis.
    Phan K; Smith SD
    J Dermatolog Treat; 2020 Dec; 31(8):810-814. PubMed ID: 31294617
    [No Abstract]   [Full Text] [Related]  

  • 15. Systematic review with meta-analysis: mycophenolate mofetil as a second-line therapy for autoimmune hepatitis.
    Santiago P; Schwartz I; Tamariz L; Levy C
    Aliment Pharmacol Ther; 2019 Apr; 49(7):830-839. PubMed ID: 30761563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and adverse events of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: systematic review and meta-analysis.
    Kamanamool N; McEvoy M; Attia J; Ingsathit A; Ngamjanyaporn P; Thakkinstian A
    Medicine (Baltimore); 2010 Jul; 89(4):227-235. PubMed ID: 20616662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of mycophenolate mofetil in patients with immune thrombocytopenic purpura: a systematic review and meta-analysis.
    Abdelwahab OA; Mechi A; Gahlan S; Hamadein FE; Kadhim H; Ismail D; Soliman Y; El-Samahy M
    Clin Rheumatol; 2024 Feb; 43(2):621-632. PubMed ID: 37981614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of mycophenolate mofetil in severe mucocutaneous lichen planus: a retrospective review of 10 patients.
    Wee JS; Shirlaw PJ; Challacombe SJ; Setterfield JF
    Br J Dermatol; 2012 Jul; 167(1):36-43. PubMed ID: 22309851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
    Zhu B; Chen N; Lin Y; Ren H; Zhang W; Wang W; Pan X; Yu H
    Nephrol Dial Transplant; 2007 Jul; 22(7):1933-42. PubMed ID: 17405792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
    Johnson C; Ahsan N; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; van Veldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
    Transplantation; 2000 Mar; 69(5):834-41. PubMed ID: 10755536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.